NKGen Biotech Statistics

Total Valuation

NKGen Biotech has a market cap or net worth of 7.34 million. The enterprise value is 38.07 million.

Market Cap	7.34M
Enterprise Value	38.07M

Important Dates

The next estimated earnings date is Thursday, April 17, 2025.

Earnings Date	Apr 17, 2025
Ex-Dividend Date	n/a

Share Statistics

NKGen Biotech has 44.95 million shares outstanding. The number of shares has increased by 103.97% in one year.

Current Share Class	n/a
Shares Outstanding	44.95M
Shares Change (YoY)	+103.97%
Shares Change (QoQ)	+71.01%
Owned by Insiders (%)	9.73%
Owned by Institutions (%)	12.75%
Float	22.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.79
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.02

Current Ratio	0.02
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.92

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-97.34%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	141.47%
Revenue Per Employee	n/a
Profits Per Employee	-769,492
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.00% in the last 52 weeks. The beta is 0.45, so NKGen Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-90.00%
50-Day Moving Average	0.39
200-Day Moving Average	0.62
Relative Strength Index (RSI)	36.50
Average Volume (20 Days)	805,044

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.30M
Pretax Income	-48.47M
Net Income	-48.48M
EBITDA	-30.11M
EBIT	-31.30M
Earnings Per Share (EPS)	-2.00

Full Income Statement

Balance Sheet

The company has 8,000 in cash and 30.74 million in debt, giving a net cash position of -30.73 million or -0.68 per share.

Cash & Cash Equivalents	8,000
Total Debt	30.74M
Net Cash	-30.73M
Net Cash Per Share	-0.68
Equity (Book Value)	-47.05M
Book Value Per Share	-1.32
Working Capital	-36.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.87M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NKGen Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-103.97%
Shareholder Yield	-103.97%
Earnings Yield	-660.47%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a